Zeitschriftenartikel zum Thema „Reverse docking“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Reverse docking" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Soto Zuluaga, Juan Pablo, Marcus Thiell und Rosa Colomé Perales. „Reverse cross-docking“. Omega 66 (Januar 2017): 48–57. http://dx.doi.org/10.1016/j.omega.2016.01.010.
Der volle Inhalt der QuelleListyani, Tiara Ajeng, und Rina Herowati. „Analisis Docking Molekuler Senyawa Derivat Phthalimide sebagai Inhibitor Non-Nukleosida HIV-1 Reverse Transcriptase“. Jurnal Farmasi Indonesia 15, Nr. 2 (01.11.2018): 123–34. http://dx.doi.org/10.31001/jfi.v15i2.445.
Der volle Inhalt der QuelleSeal, Abhik, Riju Aykkal und Mriganka Ghosh Ghosh. „Docking study of HIV-1 reverse transcriptase with phytochemicals“. Bioinformation 5, Nr. 10 (15.02.2011): 430–39. http://dx.doi.org/10.6026/97320630005430.
Der volle Inhalt der QuellePark, Kichul, und Art E. Cho. „Using reverse docking to identify potential targets for ginsenosides“. Journal of Ginseng Research 41, Nr. 4 (Oktober 2017): 534–39. http://dx.doi.org/10.1016/j.jgr.2016.10.005.
Der volle Inhalt der QuelleDA SILVA, CARLOS H. T. P., IVONE CARVALHO und CARLTON A. TAFT. „MOLECULAR DYNAMICS, DOCKING, DENSITY FUNCTIONAL, AND ADMET STUDIES OF HIV-1 REVERSE TRANSCRIPTASE INHIBITORS“. Journal of Theoretical and Computational Chemistry 05, Nr. 03 (September 2006): 579–86. http://dx.doi.org/10.1142/s0219633606002441.
Der volle Inhalt der QuelleResti, Lady Ichwana, Herman Mawengkang und Elly Rosmaini. „Mathematical Model for Vehicle Routing and Scheduling with Forward and Reverse Logistics“. Sinkron 8, Nr. 3 (01.07.2023): 1536–43. http://dx.doi.org/10.33395/sinkron.v8i3.12599.
Der volle Inhalt der QuelleWang, Yan, Aidong Wang, Jianhua Wang, Xiaoran Wu, Yijie Sun und Yan Wu. „Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase“. Molecules 27, Nr. 21 (29.10.2022): 7348. http://dx.doi.org/10.3390/molecules27217348.
Der volle Inhalt der QuelleByler, Kendall, und William Setzer. „Protein Targets of Frankincense: A Reverse Docking Analysis of Terpenoids from Boswellia Oleo-Gum Resins“. Medicines 5, Nr. 3 (31.08.2018): 96. http://dx.doi.org/10.3390/medicines5030096.
Der volle Inhalt der QuelleRuswanto, Ruswanto, Richa Mardianingrum, Siswandono Siswandono und Dini Kesuma. „Reverse Docking, Molecular Docking, Absorption, Distribution, and Toxicity Prediction of Artemisinin as an Anti-diabetic Candidate“. Molekul 15, Nr. 2 (27.07.2020): 88. http://dx.doi.org/10.20884/1.jm.2020.15.2.579.
Der volle Inhalt der QuelleRiza, Hafrizal, Andhi Fahrurroji, Arif Wicaksono, Ahmad Kharis Nugroho und Sudibyo Martono. „DOCKING STUDY OF METHYL HESPERIDIN AS NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR“. International Journal of Pharmacy and Pharmaceutical Sciences 10, Nr. 3 (01.03.2018): 85. http://dx.doi.org/10.22159/ijpps.2018v10i3.22724.
Der volle Inhalt der Quelle., T. B. Kakade. „Homology Modeling and Docking Studies on HIV Reverse Transcriptase Inhibitors“. Journal of Current Pharma Research 3, Nr. 3 (15.05.2013): 965–82. http://dx.doi.org/10.33786/jcpr.2013.v03i03.010.
Der volle Inhalt der QuelleSaleem, Mehmood, Mehar, Khan, Khan, Ashraf, Ali et al. „Bioassay Directed Isolation, Biological Evaluation and in Silico Studies of New Isolates from Pteris cretica L.“ Antioxidants 8, Nr. 7 (19.07.2019): 231. http://dx.doi.org/10.3390/antiox8070231.
Der volle Inhalt der QuelleIksan, Muhamad, Frida M. Yusuf, Fitriani Fitriani B und Wa Ode Al Zarliani. „Antipyretic Drug Candidates Through Reverse Docking Techniques Used In Science Learning“. Jurnal Penelitian Pendidikan IPA 9, Nr. 8 (25.08.2023): 6398–405. http://dx.doi.org/10.29303/jppipa.v9i8.4863.
Der volle Inhalt der QuelleTong, Jianbo, Shan Lei, Pei Zhan, Shangshang Qin und Yang Wang. „QSAR and Docking Studies of DATA Analogues as HIV-1 Reverse Transcriptase Inhibitors“. Letters in Drug Design & Discovery 16, Nr. 2 (29.11.2018): 153–59. http://dx.doi.org/10.2174/1570180815666180413152636.
Der volle Inhalt der QuelleSavita, Mahendra Kumar, Neha Bora, Ruby Singh und Prachi Srivastava. „Screening of camphene as a potential inhibitor targeting SARS-CoV-2 various structural and functional mutants: Through reverse docking approach“. Environmental Health Engineering and Management 10, Nr. 2 (27.05.2023): 123–29. http://dx.doi.org/10.34172/ehem.2023.14.
Der volle Inhalt der QuelleDarme, Pierre, Manuel Dauchez, Arnaud Renard, Laurence Voutquenne-Nazabadioko, Dominique Aubert, Sandie Escotte-Binet, Jean-Hugues Renault, Isabelle Villena, Luiz-Angelo Steffenel und Stéphanie Baud. „AMIDE v2: High-Throughput Screening Based on AutoDock-GPU and Improved Workflow Leading to Better Performance and Reliability“. International Journal of Molecular Sciences 22, Nr. 14 (13.07.2021): 7489. http://dx.doi.org/10.3390/ijms22147489.
Der volle Inhalt der QuelleKotadiya, Manisha, und Ravi Ajudia. „In-silico Docking and ADME Studies of Natural Phytoconstituents from Different Medicinal Plants as Potential HIV Reverse Transcriptase Inhibitors“. INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE 15, Nr. 01 (25.03.2024): 115–18. http://dx.doi.org/10.25258/ijpqa.15.1.18.
Der volle Inhalt der QuelleKharkar, Prashant S., Sona Warrier und Ram S. Gaud. „Reverse docking: a powerful tool for drug repositioning and drug rescue“. Future Medicinal Chemistry 6, Nr. 3 (März 2014): 333–42. http://dx.doi.org/10.4155/fmc.13.207.
Der volle Inhalt der QuelleKawsar, Sarkar Mohammad Abe, Mohammed Anowar Hosen, Tasneem Sultana Chowdhury, Kazi Masud Rana, Yuki Fujii und Yasuhiro Ozeki. „Thermochemical, PASS, Molecular Docking, Drug-Likeness and In Silico ADMET Prediction of Cytidine Derivatives against HIV-1 Reverse Transcriptase“. Revista de Chimie 72, Nr. 3 (29.07.2021): 159–78. http://dx.doi.org/10.37358/rc.21.3.8446.
Der volle Inhalt der QuelleEarlia, Nanda, Muslem, Rivansyah Suhendra, Mohamad Amin, C. R. S. Prakoeswa, Khairan und Rinaldi Idroes. „GC/MS Analysis of Fatty Acids on Pliek U Oil and Its Pharmacological Study by Molecular Docking to Filaggrin as a Drug Candidate in Atopic Dermatitis Treatment“. Scientific World Journal 2019 (03.11.2019): 1–7. http://dx.doi.org/10.1155/2019/8605743.
Der volle Inhalt der QuelleAldholmi, Mohammed, Rizwan Ahmad, Mohammad Habeeb Shaikh, Ayad Mohammed Salem, Maher Alqurashi und Mansour Alturki. „Anti-Infective Activity of Momordica charantia Extract with Molecular Docking of Its Triterpenoid Glycosides“. Antibiotics 13, Nr. 6 (11.06.2024): 544. http://dx.doi.org/10.3390/antibiotics13060544.
Der volle Inhalt der QuelleHarriman, D. Joseph, und Ghislain Deslongchamps. „Reverse-docking as a computational tool for the study of asymmetric organocatalysis“. Journal of Computer-Aided Molecular Design 18, Nr. 5 (Mai 2004): 303–8. http://dx.doi.org/10.1023/b:jcam.0000047813.47656.36.
Der volle Inhalt der QuelleZhang, Haiping, Jianbo Pan, Xuli Wu, Ai-Ren Zuo, Yanjie Wei und Zhi-Liang Ji. „Large-Scale Target Identification of Herbal Medicine Using a Reverse Docking Approach“. ACS Omega 4, Nr. 6 (04.06.2019): 9710–19. http://dx.doi.org/10.1021/acsomega.9b00020.
Der volle Inhalt der QuelleHarriman, D. Joseph, und Ghislain Deslongchamps. „Reverse-docking study of the TADDOL-catalyzed asymmetric hetero-Diels–Alder reaction“. Journal of Molecular Modeling 12, Nr. 6 (23.02.2006): 793–97. http://dx.doi.org/10.1007/s00894-006-0097-z.
Der volle Inhalt der QuelleLee, Aeri, Kyoungyeul Lee und Dongsup Kim. „Using reverse docking for target identification and its applications for drug discovery“. Expert Opinion on Drug Discovery 11, Nr. 7 (Juni 2016): 707–15. http://dx.doi.org/10.1080/17460441.2016.1190706.
Der volle Inhalt der QuelleChandra, Priyanka, Swastika Ganguly und Soikata Karmakar. „Comparative Studies of Various NNRTIs in the Active Site of Different HIV-1RT Receptors“. Chemistry Proceedings 3, Nr. 1 (14.11.2020): 33. http://dx.doi.org/10.3390/ecsoc-24-08313.
Der volle Inhalt der QuelleK., Sony Jacob, und Swastika Ganguly. „A BATTLE AGAINST AIDS: NEW PYRAZOLE KEY TO AN OLDER LOCK-REVERSE TRANSCRIPTASE“. International Journal of Pharmacy and Pharmaceutical Sciences 8, Nr. 11 (28.10.2016): 75. http://dx.doi.org/10.22159/ijpps.2016v8i11.12634.
Der volle Inhalt der QuelleTshering, Kipchu, und Mir Misbahuddin. „In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer“. Bangabandhu Sheikh Mujib Medical University Journal 9, Nr. 3 (21.09.2016): 164. http://dx.doi.org/10.3329/bsmmuj.v9i3.29650.
Der volle Inhalt der QuelleWang, Junmei, Xinshan Kang, Irwin D. Kuntz und Peter A. Kollman. „Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM−PB/SA“. Journal of Medicinal Chemistry 48, Nr. 7 (April 2005): 2432–44. http://dx.doi.org/10.1021/jm049606e.
Der volle Inhalt der QuelleNugraha, Rivo YB, Icha FD Faratisha, Kana Mardhiyyah, Dio G. Ariel, Fitria F. Putri, Nafisatuzzamrudah, Sri Winarsih, Teguh W. Sardjono und Loeki E. Fitri. „Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach“. BioMed Research International 2020 (09.01.2020): 1–15. http://dx.doi.org/10.1155/2020/6135696.
Der volle Inhalt der QuelleTien, Nguyen Truong, und Bui Tho Thanh. „Predicting binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase using molecular docking“. Science and Technology Development Journal - Natural Sciences 2, Nr. 1 (06.01.2019): 53–58. http://dx.doi.org/10.32508/stdjns.v2i1.674.
Der volle Inhalt der QuelleKhan, Mahmood-ul-Hassan, Shahid Hameed, Muhammad Farman, Najim A. Al-Masoudi und Helen Stoeckli-Evans. „Synthesis, anti-HIV activity and molecular modeling study of 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives“. Zeitschrift für Naturforschung B 70, Nr. 8 (01.08.2015): 609–16. http://dx.doi.org/10.1515/znb-2015-0032.
Der volle Inhalt der QuelleKonyar, Dilan, und Muhammed Tılahun Muhammed. „MOLECULAR DOCKING AND MOLECULAR DYNAMICS SIMULATIONS INHIBITION AGAINST OF HUMAN TELOMERASE BY NUCLEOSIDE AND NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs/NNRTIs)“. Ankara Universitesi Eczacilik Fakultesi Dergisi 48, Nr. 2 (17.04.2024): 18. http://dx.doi.org/10.33483/jfpau.1444259.
Der volle Inhalt der QuelleTarasova, Olga, Vladimir Poroikov und Alexander Veselovsky. „Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review“. Molecules 23, Nr. 5 (21.05.2018): 1233. http://dx.doi.org/10.3390/molecules23051233.
Der volle Inhalt der QuelleFan, Shengjun, Qiang Geng, Zhenyu Pan, Xin Li, Lu Tie, Yan Pan und Xuejun Li. „Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach“. BMC Systems Biology 6, Nr. 1 (2012): 152. http://dx.doi.org/10.1186/1752-0509-6-152.
Der volle Inhalt der QuelleBillones, Junie. „Reverse docking study unravels the potential Mycobacterium tuberculosis enzyme targets of Agelasine F“. Oriental Journal of Chemistry 32, Nr. 2 (25.04.2016): 851–58. http://dx.doi.org/10.13005/ojc/320210.
Der volle Inhalt der QuelleJoseph Harriman, D., Glen F. Deleavey, Andreas Lambropoulos und Ghislain Deslongchamps. „Reverse-docking study of the organocatalyzed asymmetric Strecker hydrocyanation of aldimines and ketimines“. Tetrahedron 63, Nr. 52 (Dezember 2007): 13032–38. http://dx.doi.org/10.1016/j.tet.2007.10.009.
Der volle Inhalt der QuelleRagno, Rino, Simona Frasca, Fabrizio Manetti, Antonella Brizzi und Silvio Massa. „HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies“. Journal of Medicinal Chemistry 48, Nr. 1 (Januar 2005): 200–212. http://dx.doi.org/10.1021/jm0493921.
Der volle Inhalt der QuelleKheirkhah, Amirsaman, und Saeid Rezaei. „Using cross-docking operations in a reverse logistics network design: a new approach“. Production Engineering 10, Nr. 2 (28.11.2015): 175–84. http://dx.doi.org/10.1007/s11740-015-0646-3.
Der volle Inhalt der QuellePitta, Eleni, Evangelia Tsolaki, Athina Geronikaki, Jovana Petrović, Jasmina Glamočlija, Marina Soković, Emmanuele Crespan, Giovanni Maga, Shome S. Bhunia und Anil K. Saxena. „4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies“. MedChemComm 6, Nr. 2 (2015): 319–26. http://dx.doi.org/10.1039/c4md00399c.
Der volle Inhalt der QuelleAlharbi, Ahmed. „Molecular docking based design of Inhibitors for viral Non-Nucleosidase as potential anti-retroviral agents“. Bioinformation 16, Nr. 10 (31.10.2020): 736–41. http://dx.doi.org/10.6026/97320630016736.
Der volle Inhalt der QuelleGong, Chang, Zihao Liu, Qun Lin, Yu Shi, Qing Luo, Yinghuan Cen, Juanmei Li, Xiaolin Fang und Wenguo Jiang. „Anti-PITPNM3 small molecular compounds reverse breast cancer metastasis by targeting PITPNM3.“ Journal of Clinical Oncology 39, Nr. 15_suppl (20.05.2021): e15005-e15005. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e15005.
Der volle Inhalt der QuelleChandra, Priyanka, Swastika Swastika und Manik Ghosh. „In Silico Studies of Piperazinyl-4-Nitroimidazole Derivatives in the Non-Nucleoside Inhibitory Binding Pocket of Human Immunodeficiency Virus-1-Reverse Transcriptase Enzyme“. INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY 33, Nr. 03 (30.09.2023): 293. http://dx.doi.org/10.59467/ijhc.2023.33.293.
Der volle Inhalt der QuelleKrishnamoorthy, Praveen K. P., Sekar Subasree, Udhayachandran Arthi, Mohammad Mobashir, Chirag Gowda und Prasanna D. Revanasiddappa. „T-cell Epitope-based Vaccine Design for Nipah Virus by Reverse Vaccinology Approach“. Combinatorial Chemistry & High Throughput Screening 23, Nr. 8 (02.11.2020): 788–96. http://dx.doi.org/10.2174/1386207323666200427114343.
Der volle Inhalt der QuelleRasyadan Taufiq Probojati, Ahmad Affan Ali Murtadlo, Md. Emdad Ullah, Sin War Naw und Dora Dayu Rahma Turista. „Molecular Docking Study of HIV-1 Antiretroviral Candidate via Reverse Transcriptase Inhibitor from Zingiber officinale var. Roscoe“. SAINSTEK International Journal on Applied Science, Advanced Technology and Informatics 1, Nr. 01 (09.06.2022): 26–31. http://dx.doi.org/10.24036/sainstek/vol1-iss01/6.
Der volle Inhalt der QuelleWang, Yueping, Jie Chang, Jiangyuan Wang, Peng Zhong, Yufang Zhang, Christopher Cong Lai und Yanping He. „3D-QSAR Studies of S-DABO Derivatives as Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors“. Letters in Drug Design & Discovery 16, Nr. 8 (08.08.2019): 868–81. http://dx.doi.org/10.2174/1570180815666180810112321.
Der volle Inhalt der QuelleMukherjee, Taniya, Isha Sangal, Biswajit Sarkar, Qais Almaamari und Tamer M. Alkadash. „How Effective Is Reverse Cross-Docking and Carbon Policies in Controlling Carbon Emission from the Fashion Industry?“ Mathematics 11, Nr. 13 (27.06.2023): 2880. http://dx.doi.org/10.3390/math11132880.
Der volle Inhalt der QuelleRotich, Winnie, Nicholas J. Sadgrove, Eduard Mas-Claret, Guillermo F. Padilla-González, Anastasia Guantai und Moses K. Langat. „HIV-1 Reverse Transcriptase Inhibition by Major Compounds in a Kenyan Multi-Herbal Composition (CareVid™): In Vitro and In Silico Contrast“. Pharmaceuticals 14, Nr. 10 (30.09.2021): 1009. http://dx.doi.org/10.3390/ph14101009.
Der volle Inhalt der QuelleIslam, Sk Injamamul, Saloa Sanjida, Sheikh Sunzid Ahmed, Mazen Almehmadi, Mamdouh Allahyani, Abdulelah Aljuaid, Ahad Amer Alsaiari und Mustafa Halawi. „Core Proteomics and Immunoinformatic Approaches to Design a Multiepitope Reverse Vaccine Candidate against Chagas Disease“. Vaccines 10, Nr. 10 (07.10.2022): 1669. http://dx.doi.org/10.3390/vaccines10101669.
Der volle Inhalt der QuelleSree Latha, Ramaswamy, Ramadoss Vijayaraj, Ettayapuram Ramaprasad Azhagiya Singam, Krishnaswamy Chitra und Venkatesan Subramanian. „3D-QSAR and Docking Studies on the HEPT Derivatives of HIV-1 Reverse Transcriptase“. Chemical Biology & Drug Design 78, Nr. 3 (29.07.2011): 418–26. http://dx.doi.org/10.1111/j.1747-0285.2011.01162.x.
Der volle Inhalt der Quelle